1. Ota, K., Kurita, S., Nishimura, M., et al.: Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man. Cancer Chemother. Res., 56: 373–385, 1972.
2. Suga, S., Hirota, Y., Shimaji, T., et al.: Chemotherapy of gastric caner—combination chemotherapy of mitomycin C, 5-fluorouracil and cytosine arabinoside. Gan no Rinsho (Japan J. of Cancer Clinics), 18: 209–213, 1972.
3. Hara, Y., Kurita, Y. and Tobita, Y.: Combined chemotherapy for solid tumors. Gan no Rinsho (Japan J. of Cancer Clinics), 21: 1057–1071, 1975.
4. Hasegawa, M., Tanabe, F., Ogawa, K., et al.: Clinical investigation of MFC therapy combined with Iysosome labilizer in 185 cases. Gan to Kagakuryoho (Cancer and Chemotherapy), 2: 437–443, 1975.
5. Takino, T., Abe, T., Takafuji, H., et al.: MFC therapy—especially for cancer in digestive organs—. Gendai no Rinsho (Modern Clinics), 7(5): 111–118, 1973.